Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report

Transplant Proc. 2023 Dec;55(10):2301-2303. doi: 10.1016/j.transproceed.2023.09.005. Epub 2023 Nov 29.

Abstract

The term monoclonal gammopathy of renal significance has been used to classify the presence of a monoclonal gammopathy or lymphoproliferative disorders that do not meet hematological criteria for myeloma but instead cause kidney damage. Mostly, post-transplant monoclonal gammopathy of renal significance occurs due to recurrent disease. In contrast, the incidence of de novo post-transplant monoclonal gammopathy of renal significance has not been established, as it is considered a rare disease, presenting a unique challenge in terms of diagnosis, management, and potential impact on graft survival. Here, we report a case of de novo monoclonal gammopathy of renal significance diagnosed after kidney transplantation and its complexity due to a concomitant chronic active antibody-mediated rejection.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Kidney
  • Kidney Diseases* / etiology
  • Kidney Transplantation* / adverse effects
  • Monoclonal Gammopathy of Undetermined Significance* / complications
  • Monoclonal Gammopathy of Undetermined Significance* / diagnosis
  • Monoclonal Gammopathy of Undetermined Significance* / epidemiology
  • Paraproteinemias* / complications
  • Paraproteinemias* / diagnosis